• No image available for this medication
    • CUROSURF

    • QTY 1.5
    • 120 MG/1.5
    • VIAL
    • Near  77381

PORACTANT ALFA (por AKT ant AL fa) prevents and treats respiratory distress syndrome (RDS), a condition that can occur in infants whose lungs are not fully developed. It works by helping the air sacs (alveoli) in the lungs stay open, which makes it easier to breathe. It belongs to a group of medications called surfactants.


CUROSURF Information

En Español En Español

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.